Please login to the form below

Not currently logged in
Email:
Password:

Q4 results

This page shows the latest Q4 results news and features for those working in and with pharma, biotech and healthcare.

Bluebird bio leans on pipeline and Zynteglo launch as revenues fall

Bluebird bio leans on pipeline and Zynteglo launch as revenues fall

Bluebird is in partnership with BMS for a BCMA-targeting cell therapy – bb2121 or ide-cel – which recently demonstrated positive top-line results in multiple myeloma. ... Despite making headway in Europe, Zynteglo – also called LentiGlobin – is

Latest news

More from news
Approximately 11 fully matching, plus 27 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics